Global Animal Model Market Size, Share, Growth Analysis Report - Forecast 2034

Global Animal Model Market: Industry Perspective

The global animal model market size was worth around USD 3.49 Billion in 2024 and is predicted to grow to around USD 6.24 Billion by 2034 with a compound annual growth rate (CAGR) of roughly 6% between 2025 and 2034. The report analyzes the global animal model market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the animal model industry.

Request Free Sample

Global Animal Model Market: Overview

The animal model refers to the animals on which biological and pathological experiments are done. They become the testing materials before they are tried in the human body. There are some protocols and guidelines to be followed while leveraging animal models for studies. Both humans and animals have similar biological and physiological structures. Though animals have a shorter lifespan, they match the genotype resemblance so much that the results are parallel. Even the organic framework of those animals aligns with humans. Scientists and researchers find the cure for any disease by testing those medicinal components on animals until their trial succeeds. They also come up with new products based on the outcome they get out of those experiments. These drugs that are tested on the animals are also validated for the efficacy of the recovery. The safety quotient of the medications is also determined through these animal model tests. They find applications in all fields like research & development, production, quality control, and academics.

Request Free Sample

Global Animal Model Market Size: Growth Drivers

Growth in drug discovery and innovations in the pharmaceutical sectors drives the market growth

Drug discovery and the emergence of vaccinations have grown exponentially in recent times due to the rise of multiple diseases and chronic illnesses. This has induced scientists and researchers to come up with new treatment methods and medications at a faster pace. Hence animal model testing has increased rapidly due to these factors thereby amplifying the global market rate substantially. Researchers across the world are focusing on genetically modified models to perfect the outcomes of any testing. The metabolic ways, life processes, and organic structures of the testing animals should match with that of humans to achieve accuracy. This factor contributes to revenue growth exclusively. Cancer disease has become more prominent in many regions and medications for treatment require strenuous testing experiments which can be achieved through animal models. Research grants and government initiatives to support such a mission are also boosting the global animal model market growth across all regions. The prevalence of the geriatric population and the prominence of chronic illness amongst them also supports the market exquisitely.

Animal models are being leveraged also to understand the intensity of diseases and the symptoms associated with them. The efficacy of vaccinations and prevention procedures are also deducted with the help of animal models to a large extent. These factors offer a huge surge in the development of healthcare sectors thereby nudging the market growth.

Restraints:

The cost of animal model studies and the strict regulations from the authorities restrain the market growth

The expensive method of study along with all the regulations implemented by the higher officials regarding animal model testing impedes market growth. There are also vivid ethical concerns from the animal protection organizations to safeguard the animals which hampers the expansion of the market. The harmful effects of these experiments on the animals disrupt their normal life rendering them physically and mentally impaired. They also lead to lethal impact on the animals which gives a lot of concern thereby restricting the market growth.

Opportunities:

Growth opportunities in the healthcare sectors and methods to improve the precision of test results provides opportunities for market expansion

In recent years, the demand for animal models in the research and development of new drugs and therapies has driven the market for animal models to expand consistently. Here are some market opportunities for animal models:

• The growth opportunities in the healthcare sector and innovative techniques to achieve precision in the testing results provides lucrative opportunities for the global animal model market. The government support rendered with the development of standard protocols allied with animal model testing to cure new diseases offers exceptional opportunities for market expansion.
• Increasing demand for personalized medicine: The expanding field of personalized medicine aims to tailor medical treatment to individual patients. Animal models can play a crucial role in the development of personalized medicine by enhancing our understanding of how different patients may react to treatments.
• Advancements in gene editing technologies: CRISPR/Cas9 and other gene editing technologies have facilitated the creation of animal models that are genetically modified to mimic human diseases. This has increased the demand for animal models that have been genetically modified for research and development.
• Rising demand for preclinical studies: For the development of new drugs and therapies, preclinical research is essential. The market for animal models is anticipated to expand as pharmaceutical and biotechnology companies continue to invest in preclinical research.

Challenges:

The high cost associated with the equipment and studies based on animal models poses a challenge to the market growth. The expensive animal model experiments and study procedures along with the facilities required for that come across as a challenge for revenue growth. The demand and leverage of these tests are restricted due to this factor which also impedes market expansion. Harmful effects on the animals due to these tests challenge market expansion.

Many new innovative programs and techniques for animal model testing have been on the rise. However, the impact it causes on the animals being tested results in their death or disruption of their regular lifestyle. This brings a lot of ethical concerns which also challenge the market expansion to some extent.

Key Insights

• As per the analysis shared by our research analyst, the global animal model market is estimated to grow annually at a CAGR of around 6% over the forecast period (2025-2034).
• Regarding revenue, the global animal model market size was valued at around USD 3.49 Billion in 2024 and is projected to reach USD 6.24 Billion by 2034.
• The animal model market is projected to grow at a significant rate due to rising demand in biomedical research, drug development, increasing prevalence of chronic diseases, and advancements in genetic engineering technologies.
• Based on Application, the Cancer segment is expected to lead the global market.
• On the basis of Animal Type, the Mice segment is growing at a high rate and will continue to dominate the global market.
• Based on the End-use, the Pharmaceutical & Biotechnology Companies segment is projected to swipe the largest market share.
• Based on region, North America is predicted to dominate the global market during the forecast period.

Global Animal Model Market: Report Scope  

Global Animal Model Market: Segmentation Analysis

The global animal model market is segmented based on Application, Animal Type, End-use, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2025 to 2034.

Based on Application, the global animal model market is divided into Cancer, Immunological Disease, Infectious Disease, Others.

On the basis of Animal Type, the global animal model market is bifurcated into Mice, Rat, Guinea Pigs, Rabbits, Hamsters, Others.

By End-use, the global animal model market is split into Pharmaceutical & Biotechnology Companies, Academic Research Institute, Contract Research Organization.

The Regional, this segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America,and the Middle East and Africa.

Recent Developments:

• In April 2024, Horizon Discovery Group created and developed IgM antibodies and obtained a license for the commercial agreement of animal model testing.
• In October 2024, Mammoth Bioscience secured a new license for the generation of CHO cells using mice testing procedures.

Global Animal Model Market: Regional Analysis

The animal model market shows varied regional dynamics, with North America dominating due to strong biomedical research infrastructure, significant government and private funding, and a high number of pharmaceutical and biotech companies engaged in drug development and preclinical studies. Europe follows closely, driven by rising investments in research and increasing adoption of advanced animal models for toxicity and efficacy testing, despite growing regulatory pressures around animal welfare. Meanwhile, the Asia-Pacific region is witnessing rapid growth, fueled by expanding pharmaceutical manufacturing, increasing R&D activities, and lower operational costs, particularly in countries like China, India, and South Korea. Other regions, including Latin America and the Middle East, are experiencing more modest growth but are gradually adopting animal models for research, supported by improving healthcare infrastructure and rising focus on drug development and disease modeling.

Global Animal Model Market: Competitive Analysis

The report provides a company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market, including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the animal model market on a global and regional basis.

The global animal model market is dominated by players like:

• Charles River Laboratories
• The Jackson Laboratory
• genOway
• Taconic Biosciences Inc.
• Janvier Labs
• Harbour BioMed
• Crown Bioscience
• Inotiv
• BIOCYTOGEN
• BioSpherix Ltd.

Global Animal Model Market: Segmentation Analysis

The global animal model market is segmented as follows;

By Application

• Cancer
• Immunological Disease
• Infectious Disease
• Others

By Animal Type

• Mice
• Rat
• Guinea Pigs
• Rabbits
• Hamsters
• Others

By End-use

• Pharmaceutical & Biotechnology Companies
• Academic Research Institute
• Contract Research Organization

Global Animal Model Market: Regional Segment Analysis

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America